The Effects of Glycine Therapy on the Fetal Outcome of Diabetic Mice

References

• Brownlee M, Vlassara H, Cerami A (1984): Nonenzymatic gly-cosylation and the pathogenesis of diabetic complications. Ann Intern Med 101: 527–537.
   PubMed Web of Science ®Google Scholar
• Carvajal G, Juarez E, Ramos G, Carvajal ME, Medina-Santillan R (1999a): Inhibition of hemoglobin glycation with glycine in induced diabetes mellitus in rats. Proc West Pharmacol Soc 42: 35–36.
   PubMedGoogle Scholar
• Carvajal G, Medina R, Juarez E, Ramos G, Carvajal ME (1999b): Effect of glycine on hemoglobin glycation in dia-betic patients. Proc West Pharmacol Soc 42: 31–32.
   PubMedGoogle Scholar
• Carvajal-Sandoval G, Juarez de Carvajal E, Ramos-Martinez G, Carvajal-Juarez ME (1995): Inhibición de la glicosilación no enzimatica de la hemoglobina en la diabetes mellitus. Rev Inst Nac Enf Resp Méx 8: 185–188.
   Google Scholar
• Engström E, Haglund A, Eriksson UJ (1991): Effects of mater-nal diabetes or in vitro hyperglycemia on uptake of palmitic and arachidonic acid by rat embryos. Pediatr Res 30: 150–153.
   PubMed Web of Science ®Google Scholar
• Eriksson U, Dahlström E, Larsson KS, Hellerström C (1982): Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy. Diabetes 31: 1–6.
   PubMed Web of Science ®Google Scholar
• Eriksson UJ, Borg LAH (1991): Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34: 325–331.
   PubMed Web of Science ®Google Scholar
• Eriksson UJ, Karlsson M, Styrud J (1987): Mechanisms of con-genital malformations in diabetic pregnancy. Biol Neonate 51: 113–118.
   PubMedGoogle Scholar
• Fein A, Magid N, Savion N, Orenstein H, Shepshelovich J, Ornoy A, Torchinsky A, Toder V (2002): Diabetes terato-genicity in mice is accompanied with distorted expression of TGF-I32 in the uterus. Teratogenesis Carcinog Mutagen 22: 59–71.
   Google Scholar
• Greenstein JP, Winitz M (1961): Glycine. Chemistry of the Amino Acids. New York-London, John Wiley & Sons, Inc.
   Google Scholar
• Khandelwal M, Reece EA, Wu KY, Borenstein M (1998): Dietary myo-inositol therapy in hyperglycemia-induced embryopathy. Teratology 57: 79–84.
   Google Scholar
• Kubow S, Yaylayan V, Mandeville S (1993): Protection by acetylsalicylic acid against hyperglycemia-induced glyca-tion and neural tube defects in cultured early somite mouse embryos. Diabetes Res 22: 145–158.
   PubMedGoogle Scholar
• Lee AT, Plump A, DeSimone C, Cerami A, Bucala R (1995): A role for DNA mutations in diabetes-associated teratogene-sis in transgenic embryos. Diabetes 44: 20–24.
   PubMed Web of Science ®Google Scholar
• Lee AT, Reis D, Eriksson UJ (1999): Hyperglycemia-induced embryonic dysmorphogenesis correlates with genomic DNA mutation frequency in vitro and in vivo. Diabetes 48: 371–376.
   PubMed Web of Science ®Google Scholar
• Miodovnik M, Mimouni F, Siddiqi TA, Khoury J, Berk MA (1990): Spontaneous abortions in repeat diabetic pregnan-cies: A relationship with glycemic control. Obstet Gynecol 75: 75–78.
   PubMedGoogle Scholar
• Peters PW (1977): Double staining of fetal skeletons for carti-lage and bone. In: Neubert D, Merker HJ, and Kwasigroch TE, eds., Methods in Prenatal Toxicology. Stuttgart, Georg Thieme Publ.
   Google Scholar
• Pollak A, Salzer HR, Lischka A, Hayde M (1988): Non-enzymatic glycation of fetal tissue in diabetic pregnancy: Estimation of the glucitollysine content of umbilical cord extracts. Acta Pcediatr Scand 77: 481–484.
   Google Scholar
• Ramakrishrian S, Sulochana KN (1993): Decrease in glycation of lens proteins by lysine and glycine by scavenging of glucose and possible mitigation of cataractogenesis. Exp Eye Res 57: 623–628. (Abstract).
   Google Scholar
• Reece EA, Homko CJ, Wu YK (1996): Multifactorial basis of the syndrome of diabetic embryopathy. Teratology 54: 171–182.
   PubMedGoogle Scholar
• Rosenn B, Miodovnik M, Combs A, Khoury J, Siddiqi TA (1994): Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol 84: 515–520.
   PubMed Web of Science ®Google Scholar
• Schleicher E, Wieland OH (1989): Protein glycation: Measure-ment and clinical relevance. J Clin Chem Clin Biochem 27: 577–587.
   PubMedGoogle Scholar
• Suhonen L, Hiilesmaa V, Teramo K (2000): Glycaemic control during early pregnancy and fetal malformations in women with Type I diabetes mellitus. Diabetologia 43: 79–82.
   PubMed Web of Science ®Google Scholar
• Torchinsky A, Toder V, Carp H, Orenstein H, Fein A (1997a): In vivo evidence for the existence of a threshold for hyper-glycemia-induced major fetal malformations: Relevance to the etiology of diabetic teratogenesis. Early Preg Biol Med 3: 27–33.
   PubMedGoogle Scholar
• Torchinsky A, Toder V, Savion J, Shepshelovich J, Orenstein H, Fein A (1997b): Immunostimulation increases the resis-tance of mouse embryos to the teratogenic effect of diabetes mellitus. Diabetologia 40: 635–640.
   PubMed Web of Science ®Google Scholar
• Uriu-Hare JY, Stern JS, Keen CL (1989): Influence of maternal dietary Zn intake on expression of diabetes-induced terato-genicity in rats. Diabetes 38: 1282–1290.
   PubMedGoogle Scholar
• Wentzel P, Eriksson UJ (1998): Antioxidants diminish develop-mental damage induced by high glucose and cyclooxy-genase inhibitors in rat embryos in vitro. Diabetes 47: 677–684.
   PubMed Web of Science ®Google Scholar
• Wilson JG (1965a): Methods for administering agents and detecting malformations in experimental animals. In: Wilson JG and Warkany J, eds. Teratology: Principles and Techniques. Chicago, Univ Chicago Press.
   Google Scholar
• Wilson JG (1965b): Embryological considerations in teratology. In: Wilson JG and Warkany J, eds., Teratology: Principles and Techniques. Chicago, Univ Chicago Press.
   Google Scholar